Global Polyglycolic Acid Suture Market Outlook
Revenue, 2024
$1.1B
Forecast, 2034
$2.3B
CAGR, 2025 - 2034
7.4%
The Polyglycolic Acid Suture industry revenue is expected to be around $1.2 billion in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. The Polyglycolic Acid Suture market demonstrates strong growth because of its expanding importance in medical applications. The medical community selects polyglycolic acid sutures because they possess high tensile strength and excellent knot security properties. The market continues to grow because of surgical procedure advancements and increasing chronic disease cases that need surgical treatment. The worldwide acceptance of polyglycolic acid sutures for wound closure and tissue repair applications has driven market growth.
Polyglycolic Acid Suture functions as a synthetic absorbable braided surgical thread which surgeons value for its excellent handling properties and reliable absorption timeline. The medical community uses this suture for soft tissue approximation and ligation procedures in ophthalmic and orthopedic and gastrointestinal surgeries. The suture has gained more popularity because of recent advances in minimally invasive surgical techniques and new suture materials and technologies.
Market Key Insights
- The Polyglycolic Acid Suture market is projected to grow from $1.1 billion in 2024 to $2.3 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across General Surgery, Orthopedic Surgery and Dental Procedures.
- Johnson & Johnson, Medtronic, Peters Surgical are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Polyglycolic Acid Suture market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.
- Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.
- Transition like Advancements in Surgical Techniques is expected to add $71 million to the Polyglycolic Acid Suture market growth by 2030.
- The Polyglycolic Acid Suture market is set to add $1.2 billion between 2024 and 2034, with manufacturer targeting Orthopedic Surgery & Dental Surgery Clinical Applications projected to gain a larger market share.
- With Rising demand for surgical procedures, and Increasing adoption of biodegradable products, Polyglycolic Acid Suture market to expand 104% between 2024 and 2034.
Opportunities in the Polyglycolic Acid Suture
The production of Polyglycolic Acid Suture through technological progress presents an encouraging growth opportunity. The manufacturing process improvements have also resulted in sutures that absorb faster and handle better for various surgical requirements.
Growth Opportunities in North America and Asia-Pacific
The North American market for Polyglycolic Acid Suture is characterized by a robust healthcare infrastructure, high adoption of advanced surgical procedures, and a significant presence of key manufacturers. The region is witnessing a growing demand for Polyglycolic Acid Suture, driven by an increasing number of surgical procedures and a growing geriatric population. The market is highly competitive, with major players such as Ethicon, Covidien, and Stryker dominating the landscape. However, opportunities for growth exist in the form of technological advancements in suture materials and a rising trend towards minimally invasive surgeries.
The Asia Pacific Polyglycolic Acid Suture market experiences growth because of better healthcare infrastructure and rising healthcare spending and higher surgical numbers. The Asia Pacific market for absorbable sutures experiences growing demand which drives the Polyglycolic Acid Suture market. The market demand centers around China Japan and India where local companies Lotus Surgicals and Samyang Biopharmaceuticals compete with international businesses. The market expands because of rising lifestyle diseases and medical tourism growth throughout this region.
Market Dynamics and Supply Chain
01
Driver: Increased Demand for Surgical Procedures and Advancements in Biodegradable Materials
The Polyglycolic Acid Suture market expands globally because developing nations perform more surgical procedures. The rising number of surgical procedures also drives this demand because chronic diseases continue to spread. Polyglycolic Acid Sutures have also become more effective and safer because of recent developments in biodegradable materials. The natural degradation properties of these sutures have also become a major reason for their rising popularity because they eliminate the need for additional surgeries to remove them.
The Polyglycolic Acid Suture market benefits from the increasing demand for minimally invasive surgical procedures. The procedures that use smaller incisions than traditional surgeries need sutures that can also effectively close wounds and promote healing. Polyglycolic Acid Sutures possess the best combination of tensile strength and biodegradability which makes them suitable for this application.
02
Restraint: High Cost of Polyglycolic Acid Suture
The high price of polyglycolic acid suture compared to conventional sutures presents a major. The expense of polyglycolic acid sutures affects healthcare provider choices because developing countries face regular budget limitations. The expensive nature of polyglycolic acid sutures acts as a barrier to their adoption which restricts market expansion.
03
Opportunity: Rising Demand for Polyglycolic Acid Suture in the Cosmetic Surgery Industry and Expansion of Polyglycolic Acid Suture Market in Emerging Economies
The cosmetic surgeryindustry'sincreasing demand for Polyglycolic Acid Suture is a significant market. The sutures high tensile strength and excellent knot security make it ideal for delicate cosmetic procedures. This trend underscores the untapped potential in the cosmetic surgery sector, where the demand for minimally invasive procedures is growing.
The growing healthcare infrastructure in emerging economies creates a promising market opportunity for Polyglycolic Acid Suture. The rising number of chronic diseases and surgical procedures throughout these regions creates growing demand for dependable suturing materials.
04
Challenge: Lack of Awareness and Training
The polyglycolic acid suture market faces a significant challenge because healthcare professionals lack sufficient knowledge about these products. The successful use of these sutures requires specific skills and knowledge. Healthcare professionals who lack proper training will not only achieve the full potential of these sutures which results in decreased market demand. The market expansion of polyglycolic acid sutures faces substantial obstacles because of insufficient awareness and training among healthcare professionals.
Supply Chain Landscape
1
Raw Material Suppliers
DupontKureha Corporation
2
Polyglycolic Acid Producers
Evonik IndustriesHuizhou Foryou Medical Devices
3
Suture Manufacturers
Ethicon IncMedtronic Plc
4
End User Industry
HospitalsAmbulatory Surgical Centers
1
Raw Material Suppliers
DupontKureha Corporation
2
Polyglycolic Acid Producers
Evonik IndustriesHuizhou Foryou Medical Devices
3
Suture Manufacturers
Ethicon IncMedtronic Plc
4
End User Industry
HospitalsAmbulatory Surgical Centers
Use Cases of Polyglycolic Acid Suture in General Surgery & Orthopedic Surgery
General Surgery : Polyglycolic Acid Suture is extensively used in general surgery due to its high tensile strength and predictable absorption. It is often preferred for procedures that require secure, long term wound support, such as abdominal, thoracic, and gynecological surgeries. Major players in this application include Ethicon Inc. and Medtronic, known for their superior quality sutures and strong market presence.
Orthopedic Surgery : The orthopedic field uses Polyglycolic Acid Suture as a preferred material for soft tissue and ligament repair procedures. The braided design of these sutures delivers superior knot security and handling performance. Sutures India Pvt Ltd and B. Braun Melsungen AG lead the market through their extensive selection of polyglycolic acid sutures which serve orthopedic applications.
Dental Procedures : The dental field uses Polyglycolic Acid Suture to close soft oral tissues after extraction procedures and periodontal surgical interventions. The suture works well in dental procedures because it glides through tissue easily and causes minimal tissue reaction. DemeTech Corporation and Peters Surgical operate as leading companies in this field because they produce premium sutures that control a substantial portion of the market.
Recent Developments
The Polyglycolic Acid Suture industry has been witnessing significant advancements in recent years. These developments are primarily driven by technological innovations and an increase in demand for more efficient medical sutures. The Polyglycolic Acid Suture, known for its superior knot pulling strength and high in vivo strength retention, is gaining popularity in the surgical world. A key market trend observed in this space is the growing preference for absorbable sutures over non absorbable ones.
December 2024 : Johnson & Johnson introduced Polyglycolic Acid Sutures as a new product line to enhance both wound recovery and patient recovery experience.
October 2024 : Medtronic launched a Polyglycolic Acid Suture that degrades naturally to minimize surgical complications after procedures.
August 2024 : The Polyglycolic Acid Sutures production capacity at Ethicon which operates as a Johnson & Johnson subsidiary increased to fulfill expanding worldwide market needs.
Impact of Industry Transitions on the Polyglycolic Acid Suture Market
As a core segment of the Medical Device industry,
the Polyglycolic Acid Suture market develops in line with broader industry shifts.
Over recent years, transitions such as Advancements in Surgical Techniques and Shift Towards Bioresorbable Materials have redefined priorities
across the Medical Device sector,
influencing how the Polyglycolic Acid Suture market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
Advancements in Surgical Techniques
Polyglycolic Acid Suture introduced a major change to surgical practices. The synthetic absorbable suture material has transformed surgical wound closure practices by delivering better healing outcomes and decreased infection risks. The combination of strong tensile properties and controlled absorption characteristics makes Polyglycolic Acid Suture the preferred material for surgeons worldwide. The medical device manufacturing industry has experienced changes because of this transition which led to improved suture design and production technology to fulfill rising Polyglycolic Acid Suture requirements. This industry transition is expected to add $71 million in the industry revenue between 2024 and 2030.
02
Shift Towards Bioresorbable Materials
The medicalindustry'sadoption of bioresorbable materials represents a significant change that Polyglycolic Acid Suture has helped drive. The sutures function without needing removal because they dissolve naturally which decreases both patient pain and the chance of post operative infections. The development of bioresorbable materials has accelerated because of this transition which has led to new innovative products that improve both patient care and surgical results.